Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Melanoma Experts Make Sense of ASCO 2020 Data and Advise on Clinical Implications

OncLive - As new data emerge in the melanoma treatment paradigm, new questions have come to light regarding neoadjuvant/adjuvant strategies, reduced dosing for immunotherapy combinations, and approaches following progression on, or resistance to, PD-1 inhibition.

Read the full article here

Related Content